Morgan Dempsey Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.94M Sell
28,378
-784
-3% -$183K 3.16% 9
2025
Q4
$6.04M Buy
29,162
+19
+0.1% +$3.76K 2.93% 11
2025
Q3
$5.4M Sell
29,143
-3,901
-12% -$668K 2.4% 22
2025
Q2
$5.05M Sell
33,044
-420
-1% -$64.6K 2.11% 25
2025
Q1
$5.55M Sell
33,464
-1,160
-3% -$182K 2.31% 23
2024
Q4
$5.01M Sell
34,624
-6,635
-16% -$1.03M 2.01% 28
2024
Q3
$6.69M Sell
41,259
-2,832
-6% -$451K 2.29% 28
2024
Q2
$6.44M Sell
44,091
-3,618
-8% -$538K 2.15% 30
2024
Q1
$7.55M Sell
47,709
-4,553
-9% -$725K 2.41% 27
2023
Q4
$8.19M Sell
52,262
-3,211
-6% -$492K 2.51% 27
2023
Q3
$8.64M Sell
55,473
-581
-1% -$95.9K 2.69% 20
2023
Q2
$9.28M Sell
56,054
-946
-2% -$153K 2.65% 18
2023
Q1
$8.84M Buy
57,000
+380
+0.7% +$61.4K 2.39% 26
2022
Q4
$10M Buy
56,620
+8,903
+19% +$1.54M 2.77% 17
2022
Q3
$7.79M Buy
47,717
+163
+0.3% +$27.6K 2.57% 22
2022
Q2
$8.44M Buy
47,554
+1,284
+3% +$229K 2.57% 25
2022
Q1
$8.2M Sell
46,270
-850
-2% -$145K 2.43% 23
2021
Q4
$8.06M Sell
47,120
-1,854
-4% -$304K 2.51% 26
2021
Q3
$7.91M Sell
48,974
-2,586
-5% -$441K 2.6% 23
2021
Q2
$8.49M Sell
51,560
-2,342
-4% -$388K 2.66% 24
2021
Q1
$8.86M Buy
53,902
+8,640
+19% +$1.4M 2.8% 19
2020
Q4
$7.12M Sell
45,262
-9,862
-18% -$1.46M 2.9% 13
2020
Q3
$8.21M Buy
55,124
+1,557
+3% +$230K 3.15% 12
2020
Q2
$7.53M Buy
53,567
+2,945
+6% +$429K 3.08% 15
2020
Q1
$6.64M Buy
50,622
+2,041
+4% +$290K 3.22% 15
2019
Q4
$7.09M Buy
48,581
+1,406
+3% +$191K 2.83% 14
2019
Q3
$6.1M Buy
47,175
+2,752
+6% +$363K 2.24% 22
2019
Q2
$6.19M Buy
44,423
+3,242
+8% +$449K 2.33% 16
2019
Q1
$5.76M Buy
41,181
+1,136
+3% +$152K 2.29% 15
2018
Q4
$5.17M Sell
40,045
-345
-0.9% -$48.1K 2.27% 13
2018
Q3
$5.58M Sell
40,390
-1,573
-4% -$209K 2.16% 15
2018
Q2
$5.09M Sell
41,963
-1,801
-4% -$225K 2.02% 17
2018
Q1
$5.61M Buy
43,764
+78
+0.2% +$10.5K 2.2% 12
2017
Q4
$6.1M Buy
43,686
+722
+2% +$101K 1.96% 15
2017
Q3
$5.58M Buy
42,964
+2,568
+6% +$340K 1.89% 16
2017
Q2
$5.34M Buy
40,396
+1,972
+5% +$252K 1.94% 14
2017
Q1
$4.78M Buy
38,424
+5,981
+18% +$714K 1.8% 18
2016
Q4
$3.74M Buy
32,443
+5,366
+20% +$620K 1.07% 26
2016
Q3
$3.2M Buy
27,077
+5,532
+26% +$671K 1.08% 27
2016
Q2
$2.61M Buy
21,545
+4,629
+27% +$526K 0.88% 36
2016
Q1
$1.83M Buy
16,916
+2,259
+15% +$234K 0.66% 59
2015
Q4
$1.51M Buy
14,657
+2,341
+19% +$235K 0.58% 59
2015
Q3
$1.15M Buy
12,316
+1,681
+16% +$163K 0.41% 77
2015
Q2
$1.04M Buy
10,635
+1,037
+11% +$104K 0.29% 83
2015
Q1
$966K Sell
9,598
-395
-4% -$40.2K 0.25% 81
2014
Q4
$1.04M Buy
9,993
+607
+6% +$64K 0.27% 75
2014
Q3
$1M Buy
9,386
+638
+7% +$66.2K 0.23% 68
2014
Q2
$915K Buy
8,748
+20
+0.2% +$2.02K 0.2% 69
2014
Q1
$857K Sell
8,728
-45
-0.5% -$4.17K 0.21% 73
2013
Q4
$803K Buy
8,773
+95
+1% +$8.76K 0.25% 71
2013
Q3
$752K Sell
8,678
-1,410
-14% -$126K 0.26% 69
2013
Q2
$866K Buy
+10,088
New +$856K 0.33% 65

Other funds holding JNJ

Morgan Dempsey Capital Management's JNJ Position: Q1 2026 in Review

Morgan Dempsey Capital Management reduced its Johnson & Johnson (JNJ) stake by 2.7% in Q1 2026, selling an estimated $183K and leaving 28,378 shares worth $6.94M. The position accounts for 3.16% of the portfolio, ranked #9.

Morgan Dempsey Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $10M in Q4 2022. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Morgan Dempsey Capital Management held 28,378 shares of Johnson & Johnson worth $6.94M as of Q1 2026.
  • Morgan Dempsey Capital Management sold 784 Johnson & Johnson shares in Q1 2026, an estimated $183K.
  • Johnson & Johnson made up 3.16% of Morgan Dempsey Capital Management's portfolio in Q1 2026, its #9 holding.
  • Morgan Dempsey Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Morgan Dempsey Capital Management's Johnson & Johnson position peaked at $10M in Q4 2022.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Morgan Dempsey Capital Management's 13F filing for Q1 2026, filed 6 May 2026.